Glucose intolerance induces anxiety-like behaviors independent of obesity and insulin resistance in a novel model of nutritional metabolic stress

Type 2 diabetes (T2D) and its comorbidities are a major public health concern. In addition to peripheral tissues, T2D also impacts the central nervous system leading to neurocognitive impairments, including memory deficits, anxiety, and depression. The metabolic determinants of these neurocognitive impairments remain unidentified. Here, we used a novel proprietary high-fat diet, in which glucose intolerance precedes weight gain, to decipher the metabolic determinants of neurocognitive affects. We show that this model exhibits anxiety-like behaviors, without eliciting depression nor recognition memory deficits. Long-term feeding leads to weight gain, brain glucose hypometabolism and impaired recognition memory alongside the early onset anxiety-like behavior. Using an established genetic model of T2D (db/db) and of diet-induced obesity we show that additional insulin resistance and obesity are associated with depressive-like behaviors and recognition memory deficits. Our findings indicate that glucose intolerance alone can elicit anxiety-like behaviors. Through this study we also provide a novel nutritional model to characterize the discrete effects of glucose intolerance on cognition, behavior, and the physiology of metabolic disease.

[1]  F. Nearchou,et al.  Prediabetes and the risk of type 2 diabetes: Investigating the roles of depressive and anxiety symptoms in the Lifelines cohort study , 2023, Diabetic medicine : a journal of the British Diabetic Association.

[2]  A. ElAli,et al.  Impaired spatial navigation and age‐dependent hippocampal synaptic dysfunction are associated with chronic inflammatory response in db/db mice , 2022, The European journal of neuroscience.

[3]  Y. Chen,et al.  High-fat diet induces depression-like phenotype via astrocyte-mediated hyperactivation of ventral hippocampal glutamatergic afferents to the nucleus accumbens , 2022, Molecular Psychiatry.

[4]  T. Thanaraj,et al.  Differentially methylated and expressed genes in familial type 1 diabetes , 2022, Scientific Reports.

[5]  N. Foster,et al.  18F-FDG PET Imaging in Neurodegenerative Dementing Disorders: Insights into Subtype Classification, Emerging Disease Categories, and Mixed Dementia with Copathologies. , 2022, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  G. Pedraza-Alva,et al.  An enriched environment re-establishes metabolic homeostasis by reducing obesity-induced inflammation , 2022, Disease models & mechanisms.

[7]  T. Amstislavskaya,et al.  Treatment with Autophagy Inducer Trehalose Alleviates Memory and Behavioral Impairments and Neuroinflammatory Brain Processes in db/db Mice , 2021, Cells.

[8]  Y. Chen,et al.  Fluoxetine ameliorates high-fat diet-induced metabolic abnormalities partially via reduced adipose triglyceride lipase-mediated adipocyte lipolysis. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[9]  F. Milagro,et al.  Diet-induced obesity in animal models: points to consider and influence on metabolic markers , 2021, Diabetology & Metabolic Syndrome.

[10]  Jue Liu,et al.  The effect of physical activity interventions on cognition function in patients with diabetes: A systematic review and meta‐analysis , 2021, Diabetes/metabolism research and reviews.

[11]  J. Graves,et al.  High-Fat Diet-Induced Weight Gain, Behavioral Deficits, and Dopamine Changes in Young C57BL/6J Mice , 2021, Frontiers in Nutrition.

[12]  A. Fallgatter,et al.  Insulin sensitivity predicts cognitive decline in individuals with prediabetes , 2020, BMJ Open Diabetes Research & Care.

[13]  M. Gotoh,et al.  Saturated fatty acid is a principal cause of anxiety-like behavior in diet-induced obese rats in relation to serum lysophosphatidyl choline level , 2019, International Journal of Obesity.

[14]  P. Iozzo,et al.  Imaging of brain glucose uptake by PET in obesity and cognitive dysfunction: life-course perspective , 2019, Endocrine connections.

[15]  C. Vorhees,et al.  Impairment of cognitive flexibility in type 2 diabetic db/db mice , 2019, Behavioural Brain Research.

[16]  R. McIntyre,et al.  Efficacy of omega-3 PUFAs in depression: A meta-analysis , 2019, Translational Psychiatry.

[17]  J. Ryu,et al.  A high-fat diet promotes depression-like behavior in mice by suppressing hypothalamic PKA signaling , 2019, Translational Psychiatry.

[18]  G. Enikolopov,et al.  Obesity-Induced Cellular Senescence Drives Anxiety and Impairs Neurogenesis , 2019, Cell metabolism.

[19]  A. P. Lima-Leopoldo,et al.  Differential Effects of High Sugar, High Lard or a Combination of Both on Nutritional, Hormonal and Cardiovascular Metabolic Profiles of Rodents , 2018, Nutrients.

[20]  Jing Shang,et al.  Normal diet Vs High fat diet - A comparative study: Behavioral and neuroimmunological changes in adolescent male mice. , 2017, Metabolic Brain Disease.

[21]  A. Eder,et al.  db/db Mice Exhibit Features of Human Type 2 Diabetes That Are Not Present in Weight-Matched C57BL/6J Mice Fed a Western Diet , 2017, Journal of diabetes research.

[22]  Y. Yang,et al.  HFD-induced energy states-dependent bidirectional control of anxiety levels in mice , 2017, International Journal of Obesity.

[23]  S. L. la Fleur,et al.  Diet-Induced Obesity and Circadian Disruption of Feeding Behavior , 2017, Front. Neurosci..

[24]  Fang Pan,et al.  The Effects of High-fat-diet Combined with Chronic Unpredictable Mild Stress on Depression-like Behavior and Leptin/LepRb in Male Rats , 2016, Scientific Reports.

[25]  G. Freund,et al.  Short-Term High-Fat Diet (HFD) Induced Anxiety-Like Behaviors and Cognitive Impairment Are Improved with Treatment by Glyburide , 2016, Front. Behav. Neurosci..

[26]  J. Quevedo,et al.  Effects of palatable cafeteria diet on cognitive and noncognitive behaviors and brain neurotrophins’ levels in mice , 2015, Metabolic Brain Disease.

[27]  K. Clément,et al.  Irf5 deficiency in macrophages promotes beneficial adipose tissue expansion and insulin sensitivity during obesity , 2015, Nature Medicine.

[28]  D. Brooks,et al.  Cortical hypermetabolism in MCI subjects: a compensatory mechanism? , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[29]  S. Fulton,et al.  Metabolic disturbances connecting obesity and depression , 2013, Front. Neurosci..

[30]  S. Fulton,et al.  Diet-induced obesity promotes depressive-like behaviour that is associated with neural adaptations in brain reward circuitry , 2013, International Journal of Obesity.

[31]  N. Castanon,et al.  Cognitive and Emotional Alterations Are Related to Hippocampal Inflammation in a Mouse Model of Metabolic Syndrome , 2011, PloS one.

[32]  G. Wegener,et al.  A high-fat diet exacerbates depressive-like behavior in the Flinders Sensitive Line (FSL) rat, a genetic model of depression , 2011, Psychoneuroendocrinology.

[33]  T. Kusakabe,et al.  Impaired CNS leptin action is implicated in depression associated with obesity. , 2011, Endocrinology.

[34]  T. Garrett,et al.  Neurobehavioral deficits in db/db diabetic mice , 2010, Physiology & Behavior.

[35]  M. Mattson,et al.  Voluntary exercise and caloric restriction enhance hippocampal dendritic spine density and BDNF levels in diabetic mice , 2009, Hippocampus.

[36]  R. McIntyre,et al.  Metabolic syndrome and major depressive disorder: Co-occurrence and pathophysiologic overlap , 2009, Current diabetes reports.

[37]  K. Strissel,et al.  Adipocyte Death, Adipose Tissue Remodeling, and Obesity Complications , 2007, Diabetes.

[38]  S. Kennedy,et al.  Should Depressive Syndromes Be Reclassified as "Metabolic Syndrome Type II"? , 2007, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[39]  M. Campbell,et al.  PANTHER: a library of protein families and subfamilies indexed by function. , 2003, Genome research.

[40]  R. Hen,et al.  Hyperactivity and impaired response habituation in hyperdopaminergic mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[41]  C. Champagne,et al.  Differential oxidation of individual dietary fatty acids in humans. , 2000, The American journal of clinical nutrition.

[42]  E. Van Schaftingen,et al.  Short‐term control of glucokinase activity: role of a regulatory protein , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  S. Schinner,et al.  Adipocyte Death, Adipose Tissue Remodeling, and Obesity Complications , 2009 .